NIH

It’s Time: The Life Raft Group Biomarker Testing Campaign – Identify Subsets & Clinical Trials

Identifying rare subsets of GIST and starting new clinical trials is critical. Read here about one researcher's clinical trial progress.

By |2021-09-27T14:37:39-04:00June 25th, 2021|Mutational Testing, News|

The LRG and NIH Collaborate on Virtual Tumor Boards to Review Challenging Cases

In this issue of LRG Science, we highlight the power of collaboration in medicine with a recap of the Virtual Tumor Board co-hosted with the NIH. Due to the pandemic, The Life Raft Group was asked to organize a Virtual Tumor Board to assure that challenging cases were presented in order to help the patients and their treating physicians develop an effective treatment plan.

By |2020-10-14T16:17:24-04:00October 14th, 2020|LRG Science, News|

Partnership for Survival – Treating the Rarest of the Rare

Our Rare Disease Day offering is a whitepaper titled 'Partnership for Survival – Treating the Rarest of the Rare' detailing how a collaboration with the NIH has become a model for other advocacy groups and researchers.

By |2020-02-28T14:30:39-05:00February 27th, 2020|Advocacy, News, Research|

Encouraging Rare Disease Connections at the NORD Conference

The National Organization for Rare Diseases (NORD) held its 2015 Breakthrough Summit October 21-22 in Arlington, Virginia. This year’s event convened top leaders from the FDA, NIH, Industry, Patient Groups, Payers and Research Institutions to [...]

By |2018-10-30T11:39:34-04:00December 16th, 2015|Advocacy, Newsletter|
Go to Top